InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Denali Therapeutics Inc.

DNLI Clue Score33
United States Fiscal year ends December CIK 0001714899 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

24
Insider
Date
Role
Action
Shares
Price
Amount
Ryan J. Watts
9 Jul 2025
President and CEO
Sold after exercise
495,282
$15.00
$7.43M
David P Schenkein
11 Nov 2024
Director
Sold after exercise
32,312
$32.87
$1.06M
David P Schenkein
11 Nov 2024
Director
Sold after exercise
27,129
$32.09
$870.57K
Alexander O. Schuth
7 Nov 2024
COFO and Secretary
Sold after exercise
300
$31.29
$9.39K
Alexander O. Schuth
7 Nov 2024
COFO and Secretary
Sold after exercise
2,925
$30.72
$89.86K
Alexander O. Schuth
7 Nov 2024
COFO and Secretary
Sold after exercise
12,333
$29.68
$366.04K
Ryan J. Watts
18 Oct 2024
President and CEO
Sold after exercise
40,000
$27.69
$1.11M
Ryan J. Watts
10 Aug 2023
President and CEO
Sold after exercise indirect
2,526
$25.03
$63.23K
Alexander O. Schuth
17 Jul 2023
COFO and Secretary
Sold after exercise indirect
10,000
$29.60
$296.00K
Ryan J. Watts
16 Jun 2023
President and CEO
Sold after exercise indirect
50,000
$31.40
$1.57M
Alexander O. Schuth
15 May 2023
COFO and Secretary
Sold after exercise indirect
800
$29.23
$23.38K
Alexander O. Schuth
15 May 2023
COFO and Secretary
Sold after exercise indirect
9,200
$28.55
$262.66K
Ryan J. Watts
21 Apr 2023
President and CEO
Sold after exercise indirect
24,800
$25.15
$623.72K
Ryan J. Watts
20 Apr 2023
President and CEO
Sold after exercise indirect
200
$25.00
$5.00K
Alexander O. Schuth
13 Apr 2023
COFO and Secretary
Sold after exercise indirect
4,898
$25.04
$122.65K
Alexander O. Schuth
12 Apr 2023
COFO and Secretary
Sold after exercise indirect
5,102
$25.04
$127.75K
Ryan J. Watts
13 Feb 2023
President and CEO
Sold after exercise indirect
25,000
$30.08
$752.00K
Ryan J. Watts
13 Feb 2023
President and CEO
Sold after exercise indirect
8,815
$30.09
$265.24K
Alexander O. Schuth
13 Feb 2023
COFO and Secretary
Sold after exercise indirect
3,497
$30.09
$105.22K
Ryan J. Watts
10 Feb 2023
President and CEO
Sold after exercise indirect
25,000
$29.10
$727.50K
Alexander O. Schuth
17 Jan 2023
COFO and Secretary
Sold after exercise indirect
114
$29.87
$3.41K
Alexander O. Schuth
17 Jan 2023
COFO and Secretary
Sold after exercise indirect
9,886
$29.53
$291.93K
Marc Tessier-Lavigne
7 Jun 2021
Director
Sold after exercise
700
$71.06
$49.74K
Marc Tessier-Lavigne
7 Jun 2021
Director
Sold after exercise
93,678
$70.35
$6.59M
Showing 250 of 516 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 397
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 68
Sales at will 387
Transactions with no price 0
Shares from compensation/vesting 63,608,485
Sales filed before the plan box existed 354
History held since 8 Dec 2017